Drug Wholesaling Moves to Fee for Service: Observations and Implications
- Topics:
- Pharmeceuticals
- Source:
- Pembroke Consulting
FREE Registration is required
Overview: There has been much movement by drug companies in altering wholesaler buying patterns through various inventory agreements, with a noticeable majority already having some agreement in place. There has been real movement by drug manufacturers to change the profit models of their wholesalers through a de-emphasis on channel incentives. The majority of larger manufacturers have moved in that direction. The traditional wholesaler compensation model revolved around the distributor being paid both by customers and by manufacturers through channel incentives (e.g., discounts, rebates, dating).
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: PDF | Size: 118KB | Date: Jan 2004 | Pages: 19





